Researchers exploring important new insight into ovarian cancer
Researchers from the Harper Cancer Research Institute, a partnership between the University of Notre Dame and Indiana University School of Medicine-South Bend, have uncovered a key element that plays a role in the spread ...
Cancer
Nov 07, 2011 |
not rated yet |
0
Fat cells in abdomen fuel spread of ovarian cancer
A large pad of fat cells that extends from the stomach and covers the intestines provides nutrients that promote the spread and growth of ovarian cancer, reports a research team based at the University of Chicago in the journal ...
Cancer
Oct 30, 2011 |
5 / 5 (1) |
0
|
Folate receptors may serve as a front door to ovarian cancer treatment
A new strategy that takes advantage of ovarian cancer's reliance on folate appears to give relapse patients extra months of life with few side effects, researchers say.
Cancer
Oct 28, 2011 |
5 / 5 (1) |
0
|
Test could detect breast cancers earlier in young, high-risk African-American women
Certain cancer signaling pathways that are activated in aggressive cancer can be detected very early, even in precancerous cells, among young African-American women at high risk for breast cancer. This may allow for earlier ...
Cancer
Sep 20, 2011 |
not rated yet |
0
New imaging technique visualizes cancer during surgery
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and ...
Cancer
Sep 19, 2011 |
not rated yet |
0
New technology used in first fluorescence-guided ovarian cancer surgery
The first fluorescence-guided surgery on an ovarian cancer patient was performed using a cancer cell "homing device" and imaging agent created by a Purdue University researcher.
Cancer
Sep 18, 2011 |
5 / 5 (2) |
0
|
Researchers find possible key to preventing chemotherapy resistance in ovarian cancer
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution ...
Cancer
Sep 15, 2011 |
not rated yet |
0
|
Study points to way of improving chemotherapy response
(Medical Xpress) -- Blocking key proteins could improve response to a common chemotherapy drug, suggests an Oxford University-led study which used cancer cells grown in the lab.
Cancer
Sep 02, 2011 |
5 / 5 (2) |
0
|
Key function of mutation in hereditary breast and ovarian cancer gene discovered
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers ...
Genetics
Sep 01, 2011 |
not rated yet |
0
|
Cell receptor could allow measles virus to target tumors
Canadian researchers have discovered that a tumor cell marker is a receptor for measles virus, suggesting the possible use of measles virus to help fight cancer. Their findings appear in the Open Access journal PLoS Pathogens on Aug ...
Cancer
Aug 25, 2011 |
not rated yet |
0
Gene found to play role in early cancer
(Medical Xpress) -- Mutations to a gene called p53 have been linked to half of all cancers, leading to tumor growth and the spread of cancerous cells. Now, a Cornell-led study identifies for the first time the mechanisms ...
Cancer
Aug 24, 2011 |
5 / 5 (2) |
0
|
Olaparib shows promise in treating ovarian cancer, even without BRCA mutations
The PARP inhibitor, olaparib, that has shown promise in women with an inherited mutation in their BRCA1 or BRCA2 gene (accounting for about 5-10% of breast and ovarian cancer cases), has, for the first time, been shown to ...
Cancer
Aug 21, 2011 |
not rated yet |
0
|
Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines
Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells. The vaccines are among the ...
Cancer
Aug 17, 2011 |
5 / 5 (1) |
0
New drug tested for hereditary breast and ovarian cancers
(Medical Xpress) -- A trial of a new drug for patients with hereditary breast or ovarian cancer at an advanced stage has been launched at the University of Oxford.
Cancer
Aug 17, 2011 |
not rated yet |
0
Study finds more effective approach against ovarian cancer
In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of ...
Cancer
Aug 08, 2011 |
not rated yet |
0
|
